logo
At record high! Nifty Financial Services emerges as best-performing sector in H1 2025, rallies nearly 16%

At record high! Nifty Financial Services emerges as best-performing sector in H1 2025, rallies nearly 16%

Mint3 days ago

The Indian financial services sector stood tall in the first half of 2025, emerging as the best-performing space among broader market segments. The Nifty Financial Services Index surged almost 16 percent year-to-date (YTD), outpacing other sectoral peers and underscoring investor confidence in the sector's robust fundamentals and improving macroeconomic backdrop.
The index touched its record high of 27,249 in intra-day deals today, reflecting a sharp 22 percent rally from its 52-week low of 22,320.85. With a 1.5 percent gain in the most recent session, the momentum remains strong as the broader market sentiment benefits from easing geopolitical risks, falling crude oil prices, and a weakening US Dollar Index, all of which are encouraging foreign portfolio inflows into Indian equities.
Domestic institutional investors (DIIs) have also been steadfast in their support, adding to the rally. Market optimism is further fueled by hopes of a healthy revival in corporate earnings in the June quarter of FY26, particularly in sectors like banking, insurance, and diversified financials.
In the past one year, the Nifty Financial Services Index has jumped 14 percent, with sustained upward momentum seen over the past four months. It added 2.7 percent in June so far, following gains of 1.5 percent in May, 4 percent in April, and 9 percent in March. The index did see some moderation early in the year, declining by nearly 1 percent in both January and February.
Among the 20 constituents of the Nifty Financial Services Index, only three stocks were in the red during H1 2025. Leading the charge was SBI Cards, which rallied a robust 47.5 percent, followed closely by MCX, which gained 41 percent in the first six months.
Other major gainers included Bajaj Finance, Bajaj Finserv, Cholamandalam Investment and Finance Company, and SBI Life, each of which delivered gains of over 30 percent in 2025 so far.
Stocks like Kotak Mahindra Bank, Shriram Finance, Muthoot Finance, HDFC Life, and HDFC Asset Management also delivered healthy returns in the 20–30 percent range, reflecting broad-based strength in the financial services sector.
However, a few laggards dragged the index slightly. REC emerged as the worst performer, declining nearly 20 percent, followed by PFC, which dropped 6.6 percent, and ICICI Prudential Life Insurance, which shed just over 1 percent.
One of the key developments supporting sentiment in financial names was the Reserve Bank of India's (RBI) announcement of final guidelines on project finance, which significantly toned down earlier draft proposals. According to Motilal Oswal Financial Services (MOSL), the most notable change is the relaxation in provisioning norms for under-construction loans.
'The final guidelines are much milder than expected and won't apply retrospectively,' MOSL said, noting that loans with financial closure already completed will continue under the old provisioning framework. This change provides relief to lenders and removes overhang on asset quality concerns for under-construction projects.
MOSL also highlighted that the revised standard asset provisioning now stands at around 1–1.25 percent, down sharply from the initially proposed 5 percent. During the operational phase, provisioning further eases to 0.4–1 percent depending on project type.
Among non-banking financial companies (NBFCs), PFC and REC are likely to benefit the most due to their high project loan exposure and adequate provisioning buffers. 'As of March 2025, Stage 1 and 2 provisioning stood at 1.13 percent and 0.95 percent, respectively,' MOSL said.
Other financial players such as Bajaj Housing Finance, LIC Housing Finance, Piramal Enterprises, and L&T Finance could face higher provisioning costs from October 2025 onwards, but these are likely to be passed on to borrowers, easing the impact on profitability, MOSL added.
Overall, the sharp rally in the Nifty Financial Services Index in H1 2025 highlights renewed investor faith in India's financial sector. As macro headwinds ease and regulatory clarity improves, the sector appears well-positioned for sustained performance. With corporate earnings recovery on the horizon and robust support from both foreign and domestic investors, the momentum in financial services stocks could persist through the remainder of the year. Key names like SBI Cards, Bajaj Finance, and MCX are already leading the charge, and broader tailwinds may continue to lift the sector further.
Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ketan Kumar Joshi named J&K Bank CFO for 3-year term, replaces Fayaz Ganai
Ketan Kumar Joshi named J&K Bank CFO for 3-year term, replaces Fayaz Ganai

Business Standard

time31 minutes ago

  • Business Standard

Ketan Kumar Joshi named J&K Bank CFO for 3-year term, replaces Fayaz Ganai

The Bank notified the appointment to the stock exchanges in accordance with Sebi Regulations Press Trust of India Srinagar The Jammu and Kashmir Bank on Sunday announced the appointment of Ketan Kumar Joshi as its new chief financial officer for a term of three years. Joshi has replaced Fayaz Ahmad Ganai, a spokesperson of the J&K Bank said. The Bank notified the appointment to the stock exchanges in accordance with Sebi Regulations. "A seasoned professional in banking and finance, Joshi brings over two decades of extensive experience across Indian and international financial institutions," the spokesperson said. Before joining the J&K Bank, Joshi served as CFO at North East Small Finance Bank Ltd. (2019-2024), where he successfully led a number of critical initiatives. He also spearheaded the bank's system migration from FIS (PROFILE) to BSG (TURING), ensuring capital growth aligned with business expansion and regulatory requirements. Joshi has served in Afghanistan with Maiwand Bank, Bakhtar Bank, and Ghazanfar Bank. He also served as senior vice president at Bank of Tokyo-Mitsubishi UFJ Ltd, Mumbai. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Contribute to stable borders: Chinese President Xi urges residents of Tibetan village bordering Arunachal Pradesh
Contribute to stable borders: Chinese President Xi urges residents of Tibetan village bordering Arunachal Pradesh

Time of India

time33 minutes ago

  • Time of India

Contribute to stable borders: Chinese President Xi urges residents of Tibetan village bordering Arunachal Pradesh

Beijing: Chinese President Xi Jinping on Sunday called on the Tibetan residents of a village situated near the Indian border to contribute towards fostering prosperity and stability in the border areas. "Learning that the village has undergone new changes in recent years and villagers' incomes have increased, I feel happy for you," Xi replied to a letter received from residents of Nyingchi, a prefecture-level area located close to the Arunachal Pradesh border. China claims Arunachal Pradesh as part of South Tibet, which is firmly rejected by India. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Memperdagangkan CFD Emas dengan salah satu spread terendah? IC Markets Mendaftar Undo Xi visited Nyingchi in 2021, becoming the only Chinese president to have visited the border areas of Tibet. Xi, in his letter, voiced hope that Nyingchi residents will, under the guidance of the Communist Party's policies to develop border areas and improve people's lives, do an even better job in protecting the natural beauty of the plateau region, developing the village's tourist brand, and contributing to building a prosperous and stable border area. Live Events In recent years, China has built a number of villages along the Tibetan border areas to ensure border security and development. In his letter, Xi also urged the people in the Tibet Autonomous Region to uphold ethnic solidarity and create a happier and better life, the state-run Xinhua news agency reported. During his 2021 visit to Nyingchi, Xi visited the Nyang River Bridge to inspect the ecological preservation in the basin of the Brahmaputra River , which is called Yarlung Zangbo in the Tibetan language. Last year, China approved the construction of the world's largest dam, stated to be the planet's biggest infrastructure project, costing USD 137 billion, on the Brahmaputra river in Tibet, which has raised concerns in the riparian states of India and Bangladesh.

Torrent Pharma to acquire controlling stake in JB Chemicals from KKR
Torrent Pharma to acquire controlling stake in JB Chemicals from KKR

Mint

time40 minutes ago

  • Mint

Torrent Pharma to acquire controlling stake in JB Chemicals from KKR

Ahmedabad-based drugmaker Torrent Pharmaceuticals is set to acquire a controlling stake in JB Chemicals and Pharmaceuticals (JB Pharma) from global investment firm KKR, at an equity valuation of ₹25,689 crore. The deal will be followed by a merger of the two entities, the company announced on Sunday evening. The deal will strengthen Torrent's presence in the Indian market, as well as facilitate its entry into the fast-growing contract development and manufacturing (CDMO) segment. Torrent will acquire a 46.39% equity stake (on a fully diluted basis) in JB Pharma through a share purchase agreement for ₹11,917 crore at ₹1,600 per share, followed by a mandatory open offer to acquire up to 26% of the company's shares from public shareholders, at an open offer price of ₹1,639.18 per share. Torrent also intends to acquire up to 2.80% of equity shares from certain employees of JB Pharma at the same share price as KKR, the company said in a release. The investment in JB Pharma yielded an over 5x return for KKR with a gross internal rate of return of about 36%, a person aware of the development, who did not wish to be quoted, told Mint. KKR has had a strong track record of healthcare investments in India, including a $600 million financing to Manipal Group recently and a 5x return on its investment in Max Healthcare in 2022. The acquisition will be followed by a merger between Torrent and JB Pharma through a scheme of arrangement. JB Pharma's shares rose 2.3% to ₹1,792.20 apiece, while those of Torrent Pharma settled 4.7% higher at ₹3,375 on the NSE on Friday. The acquisition will provide Torrent access to a fast-growing India franchise, with JB's leading brands in the chronic segment, and entry into untapped therapeutic areas like ophthalmology, strengthen Torrent's market share in the Indian market, and facilitate its entry into the CDMO segment. It will also aid consolidation in key international markets, the company said. 'Torrent's deep India presence and JB Pharma's fast growing India business, combined with the CDMO and international footprint, offers immense potential to scale both revenue and profitability," Samir Mehta, executive chairman, Torrent Pharmaceuticals, said in the statement. 'Moreover, the CDMO platform provides a new long-term avenue of growth for Torrent," he added. Torrent Pharma was engaged in prolonged talks to acquire KKR's stake in JB Pharma last year. The deal, however, fell through over valuation concerns. KKR acquired a 54% stake in JB Pharma from the promoters, the Mody family, in July 2020 for about ₹3,100 crore, or ₹745 per share. The investment firm sold over 5% of stake in the company in March 2025 through block deals for ₹1,459 crore, bringing its holding down to 47.84%. Torrent Pharmaceuticals has grown over the years through inorganic moves. In 2017, it acquired women's healthcare brands from Novartis, as well as Unichem's Indian branded business along with its Sikkim plant. In 2022, it acquired Curatio Healthcare for ₹2,000 crore. In an interview with the Economic Times earlier this month, Torrent's managing director-designate Aman Mehta said the company is aiming to be one of the top three pharma companies in the Indian market in the next three to five years. JB Pharma is one of the fastest growing pharma companies in India, and comes with flagship brands such as Cilacar, Metrogyl, Nicardia and Rantac. The company also exports its finished formulations to over 40 countries, including the US, and is a leading CDMO player in the segment of medicated lozenges. JB Pharma recorded revenue of ₹3,918 crore in FY24-25, growing 12% year-on-year. Of this, its revenue from the domestic market was ₹2,269 crore, growing 20% YoY. 'Over the past five years, JB Pharma has emerged as one of India's fastest growing pharmaceutical players, owing to KKR's strategic guidance, stewardship of our independent directors and a focused strategic and executional excellence by the management team. We have built a strong foundation to deliver market-leading growth as well as consistent improvement in profitability in the medium and long term," said Nikhil Chopra, chief executive officer and whole time director of JB Pharma.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store